Justin Xiang
Oprichter bij Syno Partners LLC
Profiel
Justin Xiang is the founder and Chief Investment Officer at Syno Partners LLC, which he founded in 2015.
He is currently a Director at Seaport Diagnostics, Inc. Dr. Xiang was also a Director at LungLife AI, Inc.
Actieve functies van Justin Xiang
| Bedrijven | Functie | Begin |
|---|---|---|
Seaport Diagnostics, Inc.
 Seaport Diagnostics, Inc. BiotechnologyHealth Technology Seaport Diagnostics, Inc. operates as a biotechnology company which develops treatments for genetically inherited diseases. It also offers DNA Tests for consumers across many categories such as nutrition, fitness, behavior tendencies, skincare, and more; provides consumers access to genetic information via mobile application; and manages human cell bank for future testing on regenerative medical therapies. The company was founded by Scott Schaus, Robin Y. Smith and Kate Blanchard on June 30, 2014 and is headquartered in Boston, MA. | Directeur/Bestuurslid | - |
Syno Partners LLC
 Syno Partners LLC Investment ManagersFinance Syno Partners LLC (Syno Partners) is a venture capital firm founded in 2015 by Justin Xiang and Joseph Weilgus. The firm is headquartered in New York. | Oprichter | 01-01-2015 |
Eerdere bekende functies van Justin Xiang
| Bedrijven | Functie | Einde |
|---|---|---|
| LUNGLIFE AI, INC. | Directeur/Bestuurslid | 01-07-2021 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| LUNGLIFE AI, INC. | Health Services |
| Bedrijven in privébezit | 2 |
|---|---|
Seaport Diagnostics, Inc.
Seaport Diagnostics, Inc. BiotechnologyHealth Technology Seaport Diagnostics, Inc. operates as a biotechnology company which develops treatments for genetically inherited diseases. It also offers DNA Tests for consumers across many categories such as nutrition, fitness, behavior tendencies, skincare, and more; provides consumers access to genetic information via mobile application; and manages human cell bank for future testing on regenerative medical therapies. The company was founded by Scott Schaus, Robin Y. Smith and Kate Blanchard on June 30, 2014 and is headquartered in Boston, MA. | Health Technology |
Syno Partners LLC
Syno Partners LLC Investment ManagersFinance Syno Partners LLC (Syno Partners) is a venture capital firm founded in 2015 by Justin Xiang and Joseph Weilgus. The firm is headquartered in New York. | Finance |
